New perspectives in cancer virotherapy: bringing the immune system into play

Immunotherapy
Nicolas BoisgeraultM Grégoire

Abstract

Despite constant advances in medically orientated cancer studies, conventional treatments by surgery, chemotherapy or radiotherapy remain partly ineffective against numerous cancers. Oncolytic virotherapy - the use of replication-competent viruses that specifically target tumor cells - has opened up new perspectives for improved treatment of these pathologies. Certain viruses demonstrate a natural, preferential tropism for tumor cells, while others can be genetically modified to show such an effect. Several of these viruses have already been used in preclinical and clinical trials in different tumor models; these studies have provided encouraging results and, thus, confirm the growing interest presented by this therapeutic strategy. The role of the immune system in the efficacy of cancer virotherapy has been poorly documented for a long time; however, several recent reports have presented evidence of synergistic effects between both direct viral oncolysis and the activation of specific, anti-tumor immune responses. These findings offer an exciting outlook for the future of cancer virotherapy.

References

Jun 8, 2001·Cancer·W J Frable
Mar 28, 2002·Human Gene Therapy·Kara L NormanPatrick W K Lee
Oct 24, 2002·Blood·Tommy AlainAnna E Kossakowska
Dec 3, 2002·Nature Reviews. Cancer·E Antonio Chiocca
Jan 11, 2003·Cancer Gene Therapy·Stephen J Russell
Mar 23, 2004·Current Gene Therapy·Dawn E PostErwin G Van Meir
May 4, 2004·Trends in Molecular Medicine·Brian D LichtyJohn C Bell
May 4, 2004·International Journal of Cancer. Journal International Du Cancer·Anna Kanerva, Akseli Hemminki
Jul 13, 2004·Reviews in Medical Virology·Neelam DhimanGregory A Poland
Aug 3, 2004·Cancer Gene Therapy·Eugene Lin, John Nemunaitis
Nov 17, 2004·Reviews in Medical Virology·Adele K Fielding
Jan 27, 2005·Viral Immunology·Glen N Barber
Nov 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Arnold I FreemanTali Siegal
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yasushi InoTomoki Todo
Mar 25, 2006·Cell Death and Differentiation·K G Wiman
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott A LaurieRobert M Lorence
Aug 8, 2006·Biotechnology Journal·Manfred SchusterRalf Kircheis
Aug 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Giulia FulciE Antonio Chiocca
Aug 23, 2006·Acta Oto-laryngologica·Yasushi FujimotoYukihiro Nishiyama
Dec 16, 2006·Current Gene Therapy·Silke Schepelmann, Caroline J Springer
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Dec 28, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elena V ShashkovaKonstantin Doronin
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sébastien J HottePierre P Major

❮ Previous
Next ❯

Citations

Jun 17, 2011·Expert Reviews in Molecular Medicine·Sonia WennierGrant McFadden
Feb 16, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ianko D IankovEvanthia Galanis
Sep 12, 2013·Molecular Cancer·David L BartlettZong Sheng Guo
Apr 16, 2013·BioMed Research International·Nicolas BoisgeraultMarc Grégoire
Apr 4, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jiqing ZhangRebecca C Auer
Dec 12, 2012·The Journal of Investigative Dermatology·Johanna K KaufmannGuy Ungerechts
Dec 8, 2015·Molecular Therapy Oncolytics·Olga V MatveevaPeter M Chumakov
May 2, 2014·Frontiers in Oncology·Shashi A Gujar, Patrick W K Lee
Jan 1, 2013·Biology·Jean-Baptiste GuillermeJean-François Fonteneau
Jan 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Baptiste GuillermeMarc Gregoire

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
genetic modifications
xenograft
transgenic

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.